SynRx Therapeutics
PrivateLast Round
Series A
Dec 8, 2025
Total Funding Raised
$28.3M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
SynRx Therapeutics is a biotechnology company that develops innovative oncology therapeutics focused on DNA damage repair pathways.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
SynRx Therapeutics Comparables
Compare SynRx Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| MOMA Therapeutics | 88% | |
| Breakpoint Therapeutics | 86% | |
| Recombination Therapeutics | 86% | |
SynRx Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Dec 8, 2025 | ||||
| Pre Seed | Nov 16, 2022 |
SynRx Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Lapam Capital | Series A, Pre Seed |
| 杭州市人才集团有限公司 | Series A |
| Zhejiang Financial Holding | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 8, 2025
$14.1M round led by Zhejiang Financial Holding.
- Nov 16, 2022
$14.2M round led by Lapam Capital.
SynRx Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about SynRx Therapeutics's valuation, stock price, and market status.